A Phase IV Investigation of Sugammadex in Outpatient Urological Procedures
Phase of Trial: Phase IV
Latest Information Update: 22 Feb 2018
At a glance
- Drugs Sugammadex (Primary) ; Glycopyrrolate; Neostigmine; Rocuronium bromide
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 29 Jan 2018 Planned End Date changed from 1 Sep 2019 to 1 Sep 2020.
- 29 Jan 2018 Status changed from active, no longer recruiting to recruiting.
- 17 Jan 2018 Status changed from recruiting to active, no longer recruiting.